PubMed 11. McCroskey LM, Hatheway CL, Fenicia L, Pasolini B, Aureli P: Characterization of an organism that produces type E botulinal toxin but which resembles Clostridium butyricum from the feces of an infant with type E botulism. J Clin Microbiol 1986,23(1):201–202.PubMed 12. Dolly O: Synaptic transmission: inhibition of neurotransmitter release by botulinum toxins. Headache 2003,43(Suppl 1):S16–24.PubMedCrossRef 13. Schiavo G, Benfenati F, Poulain B, Rossetto O, Polverino de Laureto P, DasGupta BR, Montecucco C: Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 1992,359(6398):832–835.PubMedCrossRef

14. Schiavo G, Rossetto O, Santucci www.selleckchem.com/products/MG132.html A, DasGupta BR, Montecucco C: Botulinum neurotoxins are zinc proteins. J Biol Chem 1992,267(33):23479–23483.PubMed VX-770 in vivo 15. Foran P, Lawrence GW, Shone CC, Foster KA, Dolly JO: Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: Palbociclib mouse correlation with its blockade of catecholamine release. Biochemistry 1996,35(8):2630–2636.PubMedCrossRef 16. Arnon SS: Creation and development of the public service orphan drug Human Botulism Immune Globulin. Pediatrics 2007,119(4):785–789.PubMedCrossRef 17. Arnon SS, Schechter R, Maslanka SE, Jewell NP, Hatheway CL: Human botulism immune globulin for the treatment of infant botulism. N Engl J Med 2006,354(5):462–471.PubMedCrossRef

18. Lindstrom M, Korkeala H: Laboratory diagnostics of botulism. Clin Microbiol Rev 2006,19(2):298–314.PubMedCrossRef 19. Solomon HM, Lilly T Jr: Bacteriological Analytical Manual online – Clostridium botulinum. In Chapter 17 – Clostridium botulinum. Edited by: RI M. Center for Food Safety and Applied Nutrition, Food and Drug Administration; 2001. 20. Campbell KD, Collins MD, East AK: Gene probes for identification of the botulinal neurotoxin gene and specific identification of neurotoxin types B, E, and F. J Clin Microbiol 1993,31(9):2255–2262.PubMed 21. Dahlenborg M, Borch E, Radstrom

P: Development of a combined selection and enrichment PCR procedure for Clostridium very botulinum Types B, E, and F and its use to determine prevalence in fecal samples from slaughtered pigs. Appl Environ Microbiol 2001,67(10):4781–4788.PubMedCrossRef 22. Fach P, Gibert M, Griffais R, Guillou JP, Popoff MR: PCR and gene probe identification of botulinum neurotoxin A-, B-, E-, F-, and G-producing Clostridium spp. and evaluation in food samples. Appl Environ Microbiol 1995,61(1):389–392.PubMed 23. Lindstrom M, Keto R, Markkula A, Nevas M, Hielm S, Korkeala H: Multiplex PCR assay for detection and identification of Clostridium botulinum types A, B, E, and F in food and fecal material. Appl Environ Microbiol 2001,67(12):5694–5699.PubMedCrossRef 24. McGrath S, Dooley JS, Haylock RW: Quantification of Clostridium botulinum toxin gene expression by competitive reverse transcription-PCR. Appl Environ Microbiol 2000,66(4):1423–1428.PubMedCrossRef 25.